ArticleFrontiers in medicine2023

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study.

Giorgia Montrucchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.